PHILADELPHIA — Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as...
PHILADELPHIA – Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the formation of its seventh and newest scientific...
PHILADELPHIA — Healthy lifestyle factors such as abstinence from smoking and drinking, low body mass index, and exercise correlated...
Awardees to receive $5,000 cash prize PHILADELPHIA — The American Association for Cancer Research (AACR) is inviting journalists to...
PHILADELPHIA – The investigational therapeutic ficlatuzumab in combination with chemotherapy showed signs of clinical efficacy in patients with relapsed/refractory...
SAN ANTONIO – Olufunmilayo I. Olopade, MD, FAACR, will receive the William L. McGuire Memorial Lecture Award at the...
PHILADELPHIA – The American Association for Cancer Research (AACR) Foundation today announced a fundraising partnership with The Battle Cancer...
WASHINGTON, D.C. – Today, American Association for Cancer Research (AACR) President David A. Tuveson, MD, PhD, FAACR, sent a...
PHILADELPHIA – The American Association for Cancer Research (AACR) Foundation today announced its FIFTY for FIFTY fundraising and awareness...